French pharma exec says he lied to FDA in attempt to steal a Novartis weight loss drug
All signs point to a busy year for M&A, as several pharma chiefs have made clear they’re on the prowl for new science. However, one executive took a rather different approach to building out the pipeline — and he could serve up to five years in prison for it.
Alain Bouaziz, a 69-year-old French citizen and United Arab Emirates resident, pleaded guilty on Friday to making false statements to the FDA in an attempt to gain control of Novartis’ weight loss drug, formerly marketed as Sanorex.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,900+ biopharma pros reading Endpoints daily — and it's free.